Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Long-Term Investments (2016)

Niagen Bioscience (NAGE) has disclosed Long-Term Investments for 2 consecutive years, with $20318.0 as the latest value for Q4 2016.

  • On a quarterly basis, Long-Term Investments changed N/A to $20318.0 in Q4 2016 year-over-year; TTM through Dec 2016 was $20318.0, a N/A change, with the full-year FY2016 number at $20318.0, changed N/A from a year prior.
  • Long-Term Investments was $20318.0 for Q4 2016 at Niagen Bioscience, roughly flat from $20318.0 in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $2.7 million in Q1 2013 to a low of $20318.0 in Q4 2016.